These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7867675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and pharmacokinetics of BAY x 7195 aerosol, a new and selective receptor antagonist of cysteinyl-leukotrienes, in normal volunteers.
    Wensing G, Heinig R, Kuhlmann J.
    Br J Clin Pharmacol; 1996 Aug; 42(2):171-8. PubMed ID: 8864314
    [Abstract] [Full Text] [Related]

  • 3. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC, Georgiou P, Howland K, Dennis M, Compton CH, Barnes NC.
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [Abstract] [Full Text] [Related]

  • 4. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V, Van De Velde V, Pauwels R, Joos G.
    Pulm Pharmacol Ther; 2008 Jun; 21(2):276-84. PubMed ID: 17611132
    [Abstract] [Full Text] [Related]

  • 5. The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig.
    Francis HP, Patel UP, Thompson AM, Carpenter TG, Gardiner PJ, Abram TS.
    Br J Pharmacol; 1998 Jan; 123(1):39-44. PubMed ID: 9484852
    [Abstract] [Full Text] [Related]

  • 6. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ, Hanby LA, Lavins BJ, Simonson SG.
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M, Imbe S, Sato R, Ikeda Y, Yamagata S, Iwanaga T, Tohda Y.
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [Abstract] [Full Text] [Related]

  • 9. The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions.
    Tanaka H, Nagai H, Takeda H, Yamaguchi S, Matsuo A, Inagaki N.
    Prostaglandins; 1995 Oct; 50(5-6):269-85. PubMed ID: 8838238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I, Reiss TF, Rochette F, Botto A, Zhang J, Kundu S, Decramer M.
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ, Glass M, Minkwitz MC.
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [Abstract] [Full Text] [Related]

  • 13. Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung.
    Sundström E, Låstbom L, Ryrfeldt A, Dahlén SE.
    J Pharmacol Exp Ther; 2003 Oct; 307(1):408-18. PubMed ID: 12954791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of a selective thromboxane A2 receptor antagonist BAY u3405 on antigen-, leukotriene C4- and leukotriene D4-induced bronchoconstriction in guinea pigs.
    Iwamoto I, Umibe T, Nakajima H, Yoshida S.
    Int Arch Allergy Immunol; 1995 Sep; 108(1):68-73. PubMed ID: 7647588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
    Frølund L, Madsen F, Nielsen J.
    Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
    [Abstract] [Full Text] [Related]

  • 18. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor.
    Casas A, Gómez FP, Dahlén B, Roca J, Barberà JA, Dahlén SE, Rodríguez-Roisin R.
    Eur Respir J; 2005 Sep; 26(3):442-8. PubMed ID: 16135725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.